Clinical Trial Update: Efficacy and Safety of Duloxetine in Chinese Solid Tumor Patients with Taxanes-induced Painful Peripheral Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy and safety of duloxetine for taxanes-induced painful peripheral neuropathy in Chinese patients with solid tumors; currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy
• Solid Tumors

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Yan Yang, MD, Ph.D | Conditions: Chemotherapy-induced Peripheral Neuropathy, Pain | Phase 2 | Status: RECRUITING